Re: Silkwood
Posted by Dave on 8/10/05
In order to combat SBS, wouldn't you need to do research with
the organisms that cause it? But then deny it.
AgraQuest is also targeting the control of mold and bacteria
that cause sick building syndrome. This problem occurs when
certain types of microorganisms infect buildings and cause
health problems including headaches, respiratory troubles,
nosebleeds and memory loss.
http://www.bizjournals.com/sacramento/stories/2002/01/07/daily9.htmlOn 8/10/05, Dave wrote:
> On 8/18/04, dave wrote:
>> (David, CA.)
>> Agraquest got me ill from exposure to pathogens and
>> allergens and set me out the door, layed off. I have been
>> sick many years.
>>
>> I filed worker's comp. and now the company slanders me by
>> saying I was fired. However, I received severance pay of
>> one month and no dismissal letter. I never expected for
>> other scientist to do this to me. I thought workplace
>> safety was of the highest concern.
>>
>> I need to find an attorney and other former employees to
>> file a class action lawsuit to prevent this from happening
>> to other laboratory workers.
>
> still sick.
>
> What ever happened to the Toxic Substance Control Act (TSCA);
> Biosafety in Microbiological and Biomedical Laboratories
> (BMBL); The Federal Food, Drug and Cosmetic Act (FFDCA) and
> the Federal Insecticide, Fungicide, and Rodenticide Act?
>
> This stuff Serenade, Bacillus subtilis, was weighed up in the
> hallway and a bathroom. There are NIOSH exposure limits and
> this proteolytic enzyme is restricted to a Class 1 containment
> at minimum.
>
> The company's own documents state:
>
> SerenadeTM WP was evaluated in a 4-hour, whole
> body, acute inhalation study in male and female Sprague-Dawley
> rats.The maximum concentration (MC) which could be aerosolized
> was 0.63 milligrams per liter (mg/L), which gave a median
> aerodynamic particle size of less than 0.4 . No mortality was
> noted during the study. Some of the clinical abnormalities
> noted in one or more animals were transient incidences of
> salvation, breathing abnormalities, decreased activity, wobbly
> gait, apparent hypothermia, hunched posture, decreased
> defecation, urine stain, decreased food consumption, and dark
> material around the facial area. Bwt loss was noted for three
> female rats (one during the 0-7 day interval, and two during
> the 7-14 day interval). However, this was a slight bwt loss
> and was not considered to be biologically significant.
>
>
http://pmep.cce.cornell.edu/profiles/fung-nemat/aceticacid-etridiazole/bacillus_subtilis/bt_petition.html
>
>
>
>
> Here are two 1969 articles about detergent enzymes:
>
> Flindt, M. H. L., "Pulmonary Disease Due to Inhalation of
> Derivatives of Bacillus subtilis Containing Proteolytic
> Enzyme." The Lancet, (1969), pp. 1177-1181.
>
> Pepys, J. et al., "Allergic Reactions of the Lungs to Enzymes
> of Bacillus subtillis." The Lancet, (1969), pp. 1181-1184.
>
>
> When is somebody going to do something about this illegal
> conduct?
>
> It does not make common sense to have a mucus membrane
> irritant and microbiology/pesticide/insecticide/fungicide
> research in the same room without telling your employees about
> the hazard.
>
> My medical bills add up to over $500,000. I get an IV every 28
> days. Surely, this is not normal.
Posts on this thread, including this one
- Agraquest got an employee sick, 8/18/04, by dave.
- Re: Agraquest got an employee sick, 8/10/05, by Dave.
- Re: Silkwood, 8/10/05, by Dave.
- Re: Agraquest got an employee sick, 8/22/05, by Similar Situation .
- Re: Agraquest got an employee sick, 9/17/05, by dave.
- Re: Agraquest got an employee sick, 9/29/05, by st.
- Re: Agraquest got an employee sick, 9/30/05, by st.
- Re: Agraquest got an employee sick, 8/26/06, by Sick.
- Re: biolab, 8/28/06, by sick.
- Re: Agraquest got an employee sick, 10/29/06, by sick.
- Re: Agraquest got an employee sick, 12/05/06, by sick.
- Re: Agraquest got an employee sick, 7/02/08, by Monique.
- Re: Agraquest got an employee sick, 9/08/08, by sick.
|
1996 - 2007. All Rights Reserved. Please review our Terms of Use, Mission Statement, and Privacy Policy.